Synapse - Find an Expert

4925 Results

Blood gene transcript analysis diagnoses bronchopulmonary NETs and identifies progressive disease

Meeting Abstract

Lewczuk, A.; Kidd, M.; Chung, K. M.; Kolasinska-Cwikla, A.; Cwikla, J.; Bodei, L.; Modlin, I.
Pancreas (2017)

Fulltext@MSK | Save

Retrospective chart review of antidepressant use in patients with carcinoid tumors

Meeting Abstract

Isenberg-Grzeda, E.; MacGregor, M.; Bergel, A.; Eagle, S.; Espi-Forcen, F.; Mehta, R.; Matsoukas, K.; Wills, J.; Reidy-Lagunes, D.; Alici, Y.
Pancreas (2017)

Fulltext@MSK | Save

Antidepressant use in patients with carcinoid tumors: Results of a systematic review

Meeting Abstract

Isenberg-Grzeda, E.; MacGregor, M.; Matsoukas, K.; Reidy-Lagunes, D.; Alici, Y.
Pancreas (2017)

Fulltext@MSK | Save

Cisplatin and etoposide or temozolomide and capecitabine in treating patients with neuroendocrine carcinoma of the gastrointestinal tract or pancreas that is metastatic or cannot be removed by surgery

Meeting Abstract

Eads, J. R.; Catalano, P.; Fisher, G. A.; Klimstra, D.; Zhang, Z.; Rubin, D.; Iagaru, A.; Wong, T. Z.; O'Dwyer, P.
Pancreas (2017)

Fulltext@MSK | Save

Pathologic patterns of inflammatory lung injury following anti-PD-1 immunotherapy in asymptomatic patients

Meeting Abstract

Velez, M. J.; Leduc, C.; Hellmann, M.; Chaft, J.; Naidoo, J.; Taube, J. M.; Forde, P. M.; Rusch, V.; Travis, W.; Rekhtman, N.
Modern Pathology (2017)

Fulltext@MSK | Save

Histologic patterns of lung cancers associated with MET exon 14 splice site alterations (MESSA): A study of 58 Cases

Meeting Abstract

Montecalvo, J.; Alex, D.; Lai, V.; Kris, M.; Drilon, A.; Arcila, M. E.; Ladanyi, M.; Rekhtman, N.; Travis, W.
Modern Pathology (2017)

Fulltext@MSK | Save

Next-generation sequencing (NGS) in pancreatic neuroendocrine tumors (panNETs): Defining differentiation and grade genetically

Meeting Abstract

Raj, N.; Hrabovsky, A.; Alexander, D.; Shah, R.; Baturk, O.; Tang, L.; Klimstra, D.; Reidy-Lagunes, D.
Pancreas (2017)

Fulltext@MSK | Save

A phase II trial of LEE011 in combination with everolimus in the treatment of advanced well differentiated neuroendocrine tumors of foregut origin